Hasil Pencarian  ::  Simpan CSV :: Kembali

"Pada kanker kolorektal dengan metastasis hati, pemilihan regimen kemoterapi memiliki peranan penting dalam manajemen penyakit. Cetuximab diberikan pada KKR dengan gen KRAS wild-type. Studi ini bertujuan untuk melihat faktor-faktor yang memengaruhi efektivitas Cetuximab pada KKR metastasis dinilai dari respon pengobatan berdasarkan CT-Scan dan kriteria RECIST. Studi ini merupakan studi deskriptif analitik retrospektif dengan desain potong lintang menggunakan data sekunder dari rekam medik pasien di RSCM dalam 3 tahun terakhir (januari 2015 – desember 2017). Dari 19 subjek, sebagian besar merupakan laki-laki dengan respon stabil pada seluruh variabel faktor (IMT normal, SGA B, tumor sisi kanan, hemikolektomi kanan, irinotecan-based agent, performance status karnofsky 80-90, derajat histologi diferensiasi sedang, dan WHO grade toxicity 0-1). Tidak didapatkan adanya respon komplit berdasarkan kriteria RECIST dan faktor yang bermakna secara statistik (p>0,05) terhadap pengaruh efektivitas Cetuximab pada kanker kolorektal metastasis hati. Berdasarkan hasil penelitian ini, dapat disimpulkan bahwa faktor-faktor tersebut tidak memengaruhi efektivitas Cetuximab pada pasien kanker kolorektal metastasis hati.

---

The choice of chemotherapy has an important role to manage a liver metastatic colorectal cancer (mCRC). Based on the newest recommendation, Cetuximab are suggestive to be given to mCRC patients with RAS wild-type. Therefore, the aim of this study is to investigate the contributing factors affecting the efficacy of Cetuximab in mCRC patients response based on CT-Scan and RECIST criteria. This study is a retrospective descriptive analtical study with cross sectional design using secondary data from RSCM’s medical records in the last 3 years (january 2015 – december 2017). From 19 subjects included in this study, most of the subjects are male with stabile disease (SD) response in all of the variable factors (normal BMI, SGA B, right-sided tumor, right-hemicolectomy, irinotecan-based chemotherapy agent, performance status Karnofsky 80-90, moderately-differentiated tumor, adn WHO grade toxicity 0-1). Complete response were not found in this study based on RECIST criteria. There were no significant factors (p>0.05) affecting the efficacy of Cetuximab in liver mCRC patients."

"Latar Belakang Nyeri merupakan salah satu gejala yang paling banyak dirasakan pasien sesudah menjalani operasi. Sebanyak lebih dari 80% pasien melaporkan nyeri akut pascabedah. Nyeri akut pascabedah dipengaruhi oleh banyak faktor preoperatif seperti usia, jenis kelamin, komorbiditas, tingkat pendidikan, jenis analgesia, nyeri prabedah, dan jenis pembedahan. Maka dari itu, peneliti ingin menginvestigasi faktor-faktor yang memengaruhi derajat nyeri akut pascabedah elektif pada pasien dewasa di RSUPN Dr. Cipto Mangunkusumo. Metode Penelitian kohort retrospektif dilakukan dengan mengambil rekam medis pada bulan 15 Juni—14 Juli 2022. Didapatkan sejumlah 137 sampel yang memenuhi kriteria inklusi dan eksklusi. Data rekam medis dianalisis dengan uji Chi-square untuk melihat hubungannya. Hasil Faktor preoperatif yaitu jenis analgesia dan nyeri prabedah bermakna signifikan secara statistik terhadap derajat nyeri akut 24 jam pascabedah (p<0,05). Faktor lain seperti usia, jenis kelamin, komorbiditas, dan tingkat pendidikan tidak memiliki hubungan bermakna yang signifikan terhadap derajat nyeri akut 24 jam pasacabedah (p>0,05). Kesimpulan Faktor preoperatif seperti jenis analgesia dan nyeri prabedah mampu memengaruhi derajat nyeri akut 24 jam pascabedah elektif pada pasien dewasa di RSUPN Dr. Cipto Mangunkusumo.

---

Introduction Pain is one of most common symptoms experienced by patients after undergoing surgery. More than 80% of patients report acute postoperative pain. Acute postoperative pain if influenced by many preoperative factors, such as age, gender, comorbidities, education level, type of analgesia, preoperative pain, and types of surgery. Therefore in this study, researcher wants to investigate the factors that influence the degree of acute postoperative pain after elective surgery in adult patients at RSUPN Dr. Cipto Mangunkosomo. Methods A retrospective cohort study was conducted by taking medical records from 15 June to 14 July 2022. A total of 137 samples that met the inclusion and exclusion criterias were obtained. Medical records data was analyzed using the Chi-square test to see the relationship between factors and acute postoperative pain. Results Preopetaive factors, such as the type of analgesia and preoperative pain, were statistically significant on the degree of acute pain 24 hourse after surgery (p<0,05). Other factors such as age, gender, comorbidities, and education level do not have a significant relationship to the degree of acute pain 24 hours after surgery (p>0,05). Conclusion Preoperative factors such as the type of analgesia and preoperative pain can influence the degree of acute pain 24 hours after elective surgery in adult patients at RSUPN Dr. Cipto Mangunkusumo."

"ABSTRAK Peningkatan angka morbiditas dan mortalitas akibat penyakit kanker di Indonesia menunjukkan bahwa permasalahan kanker ini semakin besar dan kompleks Salah satunya adalah adanya keterlambatan pasien kanker untuk mendapatkan terapi definitif yang disebabkan oleh faktor faktor yang berasal dari pasien sendiri Penelitian ini merupakan studi analisis deskriptif menggunakan metode campuran kuantitatif dan kualitatif untuk mengetahui data insidens keterlambatan terapi karena keterlambatan pasien pada pasien kanker yang dirujuk ke Departemen Radioterapi RSUPN Dr Cipto Mangunkusmo pada bulan Mei Agustus 2015 serta mengevaluasi faktor faktor apa saja yang mempengaruhi keterlambatan pasien tersebut Terdapat 294 orang pasien yang diikutsertakan dalam penelitian ini setelah mendapatkan persetujuan tertulis Sebagian besar pasien 71 4 adalah perempuan dan 141 orang 48 bekerja sebagai ibu rumah tangga Rentang umur terbanyak adalah 36 50 tahun yaitu sebanyak 132 pasien 44 9 dan hampir seluruh pasien 91 8 telah menikah Keterlambatan terapi didapatkan pada 153 orang pasien 52 dan 67 orang di antaranya 43 8 memiliki riwayat pengobatan alternatif yang dilakukan dalam interval waktu setelah timbul keluhan pertama kali dan atau setelah pasien melakukan konsultasi medis pertama kali Analisis statistik menunjukkan adanya hubungan yang signifikan antara faktor usia p 0 047 pendidikan p 0 047 dan riwayat pengobatan alternatif p 0 0001 dengan keterlambatan terapi Adanya rasa takut untuk berobat secara medis atau menjalani tindakan medis menjadi alasan 51 orang pasien untuk memilih pengobatan alternatif Oleh karena itu diperlukan pengawasan dan evaluasi terhadap pengobatan alternatif terutama yang menyangkut kualitas efikasi dan keamanannya ABSTRACT Increased morbidity and mortality due to cancer in Indonesia showed that this problem has become more complex and significant One of the problems pointed out is regarding a delay in cancer patients to receive definitive therapy caused by factors derived from the patients themselves This study is a descriptive analysis using combination of quantitative and qualitative methods to determine the incidence of treatment delay due to patient delay in cancer patients who were referred to Radiotherapy Department Dr Cipto Mangunkusmo hospital during May August 2015 and to evaluate factors that influence the patient delay There are 294 patients enrolled in this study after obtaining a written consent Most of the patients 71 4 were women and 141 48 work as a housewife The largest age range was 36 50 years with 132 patients 44 9 and almost all patients 91 8 were married Delay in treatment obtained in 153 patients 52 and 67 of them 43 8 had a history of alternative medicine that is performed in a time interval after the patients experienced first complaints and or after patients had their first medical consultation Statistical analysis showed a significant relationship between age p 0 047 educational level p 0 047 and history of alternative medicine p 0 0001 with the treatment delay The fear of being treated medically or undergo a medical procedure has become the major reasons found in 51 patients to choose the alternative treatment Therefore it is necessary to conduct monitoring and evaluation of alternative medicine especially concerning the quality efficacy and its safety ;Increased morbidity and mortality due to cancer in Indonesia showed that this problem has become more complex and significant One of the problems pointed out is regarding a delay in cancer patients to receive definitive therapy caused by factors derived from the patients themselves This study is a descriptive analysis using combination of quantitative and qualitative methods to determine the incidence of treatment delay due to patient delay in cancer patients who were referred to Radiotherapy Department Dr Cipto Mangunkusmo hospital during May August 2015 and to evaluate factors that influence the patient delay There are 294 patients enrolled in this study after obtaining a written consent Most of the patients 71 4 were women and 141 48 work as a housewife The largest age range was 36 50 years with 132 patients 44 9 and almost all patients 91 8 were married Delay in treatment obtained in 153 patients 52 and 67 of them 43 8 had a history of alternative medicine that is performed in a time interval after the patients experienced first complaints and or after patients had their first medical consultation Statistical analysis showed a significant relationship between age p 0 047 educational level p 0 047 and history of alternative medicine p 0 0001 with the treatment delay The fear of being treated medically or undergo a medical procedure has become the major reasons found in 51 patients to choose the alternative treatment Therefore it is necessary to conduct monitoring and evaluation of alternative medicine especially concerning the quality efficacy and its safety ;Increased morbidity and mortality due to cancer in Indonesia showed that this problem has become more complex and significant One of the problems pointed out is regarding a delay in cancer patients to receive definitive therapy caused by factors derived from the patients themselves This study is a descriptive analysis using combination of quantitative and qualitative methods to determine the incidence of treatment delay due to patient delay in cancer patients who were referred to Radiotherapy Department Dr Cipto Mangunkusmo hospital during May August 2015 and to evaluate factors that influence the patient delay There are 294 patients enrolled in this study after obtaining a written consent Most of the patients 71 4 were women and 141 48 work as a housewife The largest age range was 36 50 years with 132 patients 44 9 and almost all patients 91 8 were married Delay in treatment obtained in 153 patients 52 and 67 of them 43 8 had a history of alternative medicine that is performed in a time interval after the patients experienced first complaints and or after patients had their first medical consultation Statistical analysis showed a significant relationship between age p 0 047 educational level p 0 047 and history of alternative medicine p 0 0001 with the treatment delay The fear of being treated medically or undergo a medical procedure has become the major reasons found in 51 patients to choose the alternative treatment Therefore it is necessary to conduct monitoring and evaluation of alternative medicine especially concerning the quality efficacy and its safety "

"ABSTRAKMenurut Jakarta Cancer Registry tahun 2012, kanker kolorektal merupakan kanker terbanyak kedua pada laki-laki dan terbanyak keempat pada perempuan di Indonesia. Pemeriksaan skrining kanker kolorektal yang saat ini tersedia memiliki berbagai keterbatasan. Matrix metalloproteinase-9 (MMP-9) adalah endopeptidase yang berperan dalam degradasi matriks ekstraseluler, dan disekresi oleh berbagai sel seperti sel tumor, sel radang, dan fibroblas. Penelitian ini bertujuan untuk mengetahui peran diagnostik MMP-9 feses dibandingkan dengan gambaran histopatologi sebagai baku emas. Desain penelitian adalah potong lintang. Penelitian dilakukan terhadap 52 subjek terduga kanker kolorektal yang menjalani kolonoskopi. Kadar MMP-9 feses diperiksa menggunakan kit MMP-9 dari R&D Systems dengan metode ELISA. Akurasi diagnostik kadar MMP-9 feses sebesar 0,855. Titik potong kadar MMP-9 feses didapatkan 1,237 ng/ml dengan sensitivitas 88,9%, spesifisitas 76,7%, nilai prediksi positif 44,4%, dan nilai prediksi negatif 97,1%. Pemeriksaan kadar MMP-9 feses dapat dipertimbangkan dalam skrining kanker kolorektal.

---

ABSTRACT

According to Jakarta Cancer Registry 2012, colorectal cancer is the second most common cancer in men and fourth in women in Indonesia. Colorectal cancer screening tests currently available, have various limitations. Matrix metalloproteinase-9 (MMP-9) is endopeptidase which plays a role in the degradation of the extracellular matrix, and is secreted by various cells such as tumor cells, inflammatory cells, and fibroblasts. This is a cross sectional study aims to determine the diagnostic role of faecal MMP-9 compared to histopathological features as gold standard. The study was conducted on 52 subjects with suspected colorectal cancers who underwent colonoscopy. The levels of faecal MMP-9 were examined using MMP-9 kit from R&D Systems using ELISA method. Diagnostic accuracy of faecal MMP-9 levels is 0.855. The cutoff point was 1.237 ng/ml with sensitivity of 88.9%, specificity of 76.7%, positive predictive value of 44.4%, and negative predictive value of 97.1%. Faecal MMP-9 can be considered as a screening test in colorectal cancer."

"Latar Belakang. Kanker kolorektal merupakan penyakit keganasan ketiga terbanyak di dunia dan memiliki mortalitas yang cukup tinggi terutama bila ditemukan pada stadium lanjut. Kesintasan pasien KKR stadium IV dan faktor yang berhubungan perlu diketahui untuk menentukan perbaikan pada tata laksana KKR. Tujuan. Mengetahui kesintasan satu tahun pasien kanker kolorektal stadium IV serta hubungan usia, lokasi tumor, lokasi metastasis, kemoterapi, terapi target, serta diferensiasi tumor dengan kesintasan dalam satu tahun Metode. Penelitian dilakukan dengan metode kohort retrospektif dengan subyek penelitian pasien kanker kolorektal stadium IV yang berobat ke RSCM sejak Januari 2018 hingga Mei 2020. Data pasien dan faktor yang berhubungan diambil dan dilakukan pengamatan selama 1 tahun sejak pasien pertama kali terdiagnosis stadium IV. Kesintasan dinilai dengan metode Kaplan-Meier dan dilanjutkan dengan uji log-rank untuk faktor yang berhubungan. Hasil. Penelitian ini berhasil mengumpulkan 214 subyek dengan kesintasan 1 tahun sebesar 43% dengan median kesintasan 11 bulan. Pasien yang memiliki berat badan kurang [HR 1,495; IK 1,028-2,173; (p=0,035)] dan tidak mendapatkan kemoterapi [HR 4,466; IK 3,027-6,588; (p=<0,001)] merupakan faktor yang bermakna secara statistic terhadap kesintasan satu tahun pasien KKR stadium IV di RSCM. Kesimpulan. Kesintasan satu tahun pasien KKR stadium IV di RSCM hampir sama dengan negara Asia lain. Pemberian kemoterapi dan berat badan kurang memiliki hubungan yang signifikan dengan mortalitas KKR stadium IV.

---

Background. Colorectal cancer is the third most common types of cancer in the world. Colorectal cancer has high mortality especially when found in later stage. The survival and its associated factors should be known to improve the cancer treatment. Objective. This study was undertaken to document one year survival for colorectal cancer and whether age, tumor side, metastatic location, chemotherapy, targeted therapy, and tumor differentiation are associated with one year survival. Methods. This study is a retrospective cohort study. The subjects are stage IV colorectal cancer patients in RSUPN Dr. Cipto Mangunkusumo since January 2018-May 2020. Data of patients and its mortality status within one year is documented since the patients diagnosed with stage IV colorectal cancer. Survival was done using Kaplan-Meier method and continued with log-rank test. Result. We collected 214 subjects and 1 year survival rate is 43% with survival median of 11 months. Patients who are underweight [HR 1,495; 95% CI 1,028-2,173; (p=0,035)] and did not received chemotherapy [HR 4,466; 95% CI 3,027-6,588; (p=<0,001)] were associated with one year survival of mCRC in RSUPN Dr. Cipto Mangunkusumo. Conclusion. One year survival for mCRC in RSUPN Cipto Mangunkusumo is similar to other Asian countries. Chemotherapy and underweight were associated with survival in 1 year observation."

"Pendahuluan: Di Indonesia, kanker rektum menempati urutan kedua kanker gastrointestinal dengan jumlah kasus baru 14.122 (4,65 %) dari semua kasus kanker, dengan jumlah kematian sebanyak 6.827 jiwa. Hal ini menunjukkan perlunya suatu terapi terstandar dalam tatalaksana kanker rektum. KPKN pada tahun 2016 telah mengeluarkan Pedoman Nasional Pelayanan Kedokteran Kanker kolorektal sebagai panduan dalam terapi, yang diterapkan di RSCM sebagai Pedoman Praktis Klinis (PPK) Kanker kolorektal. Penelitian ini bertujuan menilai kepatuhan terapi dalam tatalaksana Kanker rektum dan hubungannya dengan kesintasan pasien.Metode: Studi kohort retrospektif ini menilai pasien kanker rektum yang menjalani radioterapi di RSCM periode Januari 2017-Juni 2018, dengan kriteria inklusi pasien non metastasis, menjalani terapi radiasi neoajuvan di RSCM, dan menggunakan BPJS. Kepatuhan terapi dinilai dengan menggunakan PPK kolorektal 2016 sebagai acuan dengan variabel kepatuhan sequence/urutan terapi, kepatuhan interval waktu terapi, dan kepatuhan kesesuaian terapi dari masing masing modalitasHasil: Terdapat 30 pasien yang masuk kriteria inklusi, dengan usia rerata 48 ± 12 tahun. Mayoritas pasien terdiagnosa stadium IIIC. Kesintasan hidup keseluruhan pasien dalam 2 tahun adalah 43,3 %. Proporsi kesintasan 2 tahun pada kelompok yang mendapatkan kepatuhan terapi adalah 50% sedangkan Kelompok yang tidak mendapat kepatuhan terapi adalah 42,3 % (p=1), Kepatuhan keseluruhan adalah 13,3%, terdapat tren kesintasan yang terlihat lebih baik untuk kelompok yang patuh dibandingkan kelompok yang tidak patuh, meskipun secara statistik tidak bermakna (p=0.317).

---

Aims: Rectal cancer cases are the second highest gastrointestinal cancer with a total of 14,122 and new cases (4.65%) of all cancer cases, with 6,827 fatalities in Indonesia. A standardized treatment in the management of rectal cancer in Indonesia is needed. In 2016, The National cancer control committee (KPKN) issued the National Guidelines for Colorectal Cancer Medicine Services as a guide in therapy, which was implemented in A National health center (RSCM) as a Clinical Practical Guide (PPK) for Colorectal Cancer. This study objected to assess adherence in the management of rectal cancer and its relationship with patient survival.

Method: This retrospective cohort study assessed the rectum cancer patients undergoing radiotherapy in the RSCM period January 2017-June 2018, with the criteria of non-metastatic patient inclusion, undergoing Neoadjuvant radiation therapy in RSCM, and using government insurance. Adherence to guidelines is assessed using PPK Colorectal 2016 as a reference to compliance therapeutic sequence, compliance interval therapy time, and compliance with therapeutic conformity of each modality.

Results: There are 30 patients include this study, with an average age of 48 ± 12 years. The majority of patients diagnosed with stage IIIC. The overall survival of the patient in 2 years is 43.3%. The proportion of 2 years in the group receiving therapeutic adherence is 50% while the group who did not get therapeutic adherence was 42.3% (P = 1), overall compliance was 13.3%, there is a trend of survival that looks better for the adherence group than the disobedient group, although statistically not significant (P = 0.317)."

"ABSTRAKPenyakit kanker merupakan penyakit yang sangat kompleks sehingga memerlukan pendekatan multidisiplin baik dalam diagnostik maupun terapi. Durasi penegakkan diagnosis dan terapi pada pasien kanker mempengaruhi hasil akhir pasien tersebut. Keterlambatan terapi dapat disebabkan oleh keterlambatan dokter dalam merujuk pada pelayanan kesehatan primer dan keterlambatan sistem pelayanan kesehatan pada proses penegakkan diagnosis dan dimulainya terapi definitif pada kanker. Penelitian ini merupakan studi analisis deskriptif menggunakan metode campuran kuantitatif dan kualitatif untuk mengetahui data insidens keterlambatan terapi pada pasien kanker yang dirujuk ke Departemen Radioterapi RSUPN Dr. Cipto Mangunkusmo pada bulan Mei - Agustus 2015 serta mengevaluasi faktor yang mempengaruhi keterlambatan tersebut. Terdapat 294 orang pasien yang diikutsertakan dalam penelitian ini setelah mendapatkan persetujuan tertulis. Pada keterlambatan terapi akibat keterlambatan dokter, dari 62 pasien yang dirujuk dari pelayanan kesehatan primer didapatkan 18 pasien (29%) mengalami keterlambatan rujukan. Keterlambatan diagnosis terjadi pada 78 pasien (26,5%). Sedangkan pada keterlambatan tindakan pengobatan terjadi pada 172 pasien (58,5%). Dari seluruh pasien didapatkan 132 pasien (45%) mengalami keterlambatan dokter dan sistem. Berdasarkan analisis statistik menunjukkan adanyan hubungan yang signifikan antara keterlambatan rujukan (p<0,01), keterlambatan diagnosis (p<0,01) dan keterlambatan tindakan pengobatan (p<0,01) dengan keterlambatan terapi akibat keterlambatan dokter dan system. Tingginya angka keterlambatan terapi kanker pada penelitian ini ditemukan akibat keterlambatan dokter dan sistem, khususnya pada keterlambatan pada penegakkan diagnosis dan tindakan pengobatan.

---

ABSTRACTCancer is a very complex disease that requires a multidisciplinary approach both in diagnostics and therapy. The duration of the diagnosis and treatment of cancer patients affect the outcome of these patients. Delay in treatment may be caused by the delay in referring physicians in primary health care and health care system delay in the commencement of the process of diagnosis and definitive therapy in cancer. This study was a descriptive analytical study using a mix of quantitative and qualitative methods to determine the incidence of therapy delays in cancer patients who were referred to the Department of Radiotherapy RSUPN Dr. Cipto Mangunkusmo in May to August for 2015 and evaluate the factors that influence the delay. There were 294 patients included in this study after obtaining written consent. Doctor's delay due to delayed treatment, from 62 patients referred from primary health care is obtained for 18 patients (29%) experienced a delay in referral. Delay in diagnosis occurred in 78 patients (26.5%). While the delay in treatment action occurred in 172 patients (58.5%). From all patients had 132 patients (45%) experienced doctor and system delay. Statistical analysis showed a significant correlation between the reference delay (p <0.01), late diagnosis (p <0.01) and delays in treatment measures (p <0.01) with a delay due to delayed therapy and doctor system. The high number of delays in cancer therapy in this study was found as a result of delays doctor and systems, in particular on the delay in diagnosis and treatment.eterlambatan terapi akibat keterlambatan dokter dan system. Tingginya angka keterlambatan terapi kanker pada penelitian ini ditemukan akibat keterlambatan dokter dan sistem, khususnya pada keterlambatan pada penegakkan diagnosis dan tindakan pengobatan."

"Tujuan : Di Indonesia, kanker payudara (KPD) menempati urutan pertama kanker pada wanita dengan jumlah kasus baru 58.256 (19,8 %) dari semua kasus kanker, dengan jumlah kematian sebanyak 22.692 jiwa. Hal ini menunjukkan perlunya suatu terapi terstandar dalam tatalaksana KPD. KPKN pada tahun 2016 telah mengeluarkan Pedoman Nasional Pelayanan Kedokteran KPD sebagai panduan dalam terapi, yang diterapkan di RSCM sebagai Pedoman Praktis Klinis (PPK) KPD. Penelitian ini bertujuan menilai kepatuhan dalam tatalaksana KPD dan hubungannya dengan kesintasan pasien.Metode : Studi kohort retrospektif ini menilai pasien KPD yang menjalani radioterapi di RSCM periode Januari 2017-Juni 2018, dengan kriteria inklusi pasien non metastasis, menjalani operasi sebagai terapi primer, dan menggunakan BPJS. Kepatuhan terapi dinilai dengan menggunakan PPK KPD 2016 sebagai acuan.Hasil : Terdapat 165 pasien yang masuk kriteria inklusi, dengan usia median 48 (28-82) tahun. Sebanyak 61% pasien terdiagnosa stadium III. Median follow-up 30 bulan. Kesintasan hidup 1 dan 2 tahun adalah 100% dan 97% pada kelompok yang mendapatkan terapi standar, lebih tinggi dibandingkan pada kelompok yang tidak mendapatkan terapi standar, yaitu 100% dan 92%. Kelompok yang tidak mendapatkan terapi tidak standar berisiko 5,38 kali lebih tinggi untuk mengalami metastasis jauh (HR 5,38; 95% IK 1,3-22,5).

---

Objective : In Indonesia, breast cancer ranks first among women with new cases of 58,256 (19.8%) of all cancer cases, with 22,692 deaths. This shows the need for a standardized therapy in the management of breast cancer. Our national guidelines, derived from The National Comprehensive Cancer Network (NCCN) are becoming a national standard of care for breast cancer, but there is still no research to asses the compliance of national guideline in Indonesia for our current clinical practice of breast cancer. This study aims to assess compliance in the management of breast cancer and its relationship with patient survival.

Methods : This retrospective cohort study assessed breast cancer patients who underwent radiotherapy at the RSCM in the period January 2017-June 2018. Therapy compliances was assessed using the breast cancer national guideline as a reference.

Results : There were 165 patients who were included in the inclusion criteria, with a median age of 48 (27-82) years. As many as 61% of patients are diagnosed with stage III. Median follow-up is 30 months. The survival rate of 1 and 2 years is 100% and 97% in the group that received standard therapy, higher than in the group that did not get standard therapy, which is 100% and 92%. The group that did not get non-standard therapy was 5,28 times more likely to have distant metastases (HR 5,28; 95% CI 1.3-22,5)."

"Kanker kolorektal diketahui berhubungan dengan massa otot yang rendah. Massa otot yang rendah dihubungkan dengan luaran klinis yang buruk. Telah diketahui bahwa asupan protein adalah salah satu faktor yang berperan dalam mempertahankan massa otot. Namun, studi-studi yang ada mengenai efek pemberian protein tinggi pada pasien kanker kolorektal terhadap massa otot belum dapat disimpulkan karena kurangnya bukti dari penelitian berkualitas baik dan intervensi pada studi yang berbeda-beda. Tujuan dari penelitian ini adalah untuk mengetahui korelasi antara asupan protein dengan indeks massa otot skelet pada pasien kanker kolorektal yang dirawat inap di Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (RSCM). Penelitian menggunakan desain potong lintang pada subjek dewasa kanker kolorektal yang dirawat inap di RSCM. Asupan protein dinilai menggunakan multiple 24 hour recall. Indeks massa otot skelet didapatkan dari pengukuran massa otot skelet dalam kilogram menggunakan BIA multifrequency, lalu dibagi dengan tinggi badan dalam meter yang dikuadratkan. Sebanyak 52,5% subjek berjenis kelamin perempuan dan 50% subjek berada pada stadium IV. Terapi yang paling banyak telah dijalani subjek adalah kombinasi pembedahan dan kemoterapi (n=16, 40%). Tidak ditemukan korelasi antara asupan protein dan indeks massa otot skelet (r = -0,04, P=0,795).

---

Colorectal cancer is known to be associated with low muscle mass. Low muscle mass is associated with poor clinical outcome. It is known that protein intake is one of the factors that play a role in maintaining muscle mass. However, the existing studies on the effect of administering high protein in colorectal cancer patients on muscle mass have not been definitively concluded due to the lack of evidence from good quality studies and differences of intervention in existing studies. The purpose of this study was to determine the correlation between protein intake and skeletal muscle mass index in colorectal cancer patients who were hospitalized at the RSUPN Dr. Cipto Mangunkusumo (RSCM). The study used a cross-sectional design on adult subjects with colorectal cancer who were hospitalized at RSCM. Protein intake was assessed using multiple 24 hour recalls. Skeletal muscle mass index was obtained from the measurement of skeletal muscle mass in kilograms using BIA multifrequency, then divided by height in meters squared. A total of 52.5% of the subjects were female and 50% of the subjects were in stage IV. The most common therapy that the subject had undergone was a combination of surgery and chemotherapy (n=16, 40%). No correlation was found between protein intake and skeletal muscle mass index (r = -0.04, P=0.795)."

"atar belakang: Prevalensi penyakit Parkinson di Indonesia terus meningkat, khususnya pada lansia. Namun, penyakit Parkinson seringkali hanya dikaitkan dengan gangguan motoriknya saja, gangguan non-motoriknya sering diabaikan. Padahal, gangguan non-motorik dapat memengaruhi kualitas hidup. Salah satu gangguan non-motorik yang sering terjadi adalah gangguan tidur. Oleh karena itu, penelitian ini bertujuan untuk memberikan gambaran gangguan tidur pada pasien penyakit Parkinson di RSUPN dr. Cipto Mangunkusumo dan faktor-faktor yang memengaruhinya. Metode: Metode penelitian ini adalah cross-sectional yang dilakukan di RSUPN dr. Cipto Mangunkusumo pada Mei sampai September 2022. Instrumen yang digunakan merupakan kuesioner dengan teknik consecutive sampling yaitu 31 pasien penyakit Parkinson. Uji univariat digunakan untuk melihat distribusi prevalensi penyakit Parkinson, uji Chi Square untuk menilai hubungan antarvariabel, dan uji Fisher’s exact untuk menilai hubungan status depresi dengan gangguan tidur. Hasil: Hasil analisis statistik menunjukkan bahwa 61.3% subjek memiliki gangguan tidur berdasarkan PSQI dan 35.5% memiliki EDS berdasarkan ESS. Terdapat hubungan yang bermakna antara faktor depresi dengan gangguan tidur berdasarkan PSQI dan ESS. Status depresi memengaruhi bermakna kejadian EDS dengan mayoritas pasien depresi ringan. Kesimpulan: Disimpulkan bahwa gangguan tidur pada pasien penyakit Parkinson di RSUPN dr. Cipto Mangunkusumo dipengaruhi oleh faktor sosiodemografi dan klinis.

---

Introduction: The prevalence of Parkinson's disease in Indonesia is increasing, especially in elderly. However, Parkinson's disease is often only associated with motor disorders, non-motor disorders are often neglected even though it can also affect quality of life. One of the non-motor disorders that often occurs is sleep disorders. Therefore, this study aims to provide an overview of sleep disorders in Parkinson's disease patients and factors that influence it. Method: A cross-sectional study was conducted at RSUPN dr. Cipto Mangunkusumo from May to September 2022. The instrument used was questionnaires with a consecutive sampling technique, namely 31 Parkinson's disease patients. Univariate test was used to see the distribution of Parkinson's disease, Chi Square test to assess the relationship between variables, and Fisher's exact test to assess the relationship between depression status and sleep disorders. Result: Statistical analysis showed that 61.3% subjects experienced sleep disorders (PSQI) and 35.5% experienced EDS (ESS). The relationship between depression and sleep disorders based on PSQI and ESS is significant. Depressive status is associated with EDS with the majority being mild depression. Conclusion: Sleep disorders in Parkinson's disease patients at dr. Cipto Mangunkusumo is influenced by sociodemographic and clinical factors."